• 160 Citations
  • 5 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


After some years working as a community pharmacist, I came to Macquarie University to do a PhD in Pharmacology. I finished my PhD in 2015, where I researched the effect of single nucleotide polymorphisms and phosphomutation of the mu-opioid receptor.

After concluding my PhD, I started working for Prof. Mark Connor and the Lambert Initiative for Cannabinoid Therapeutics. The project focus in the creation of platforms for the cell based elucidation of potential cannabinoid mechanisms of action in epilepsies.

Now I am engaged in teaching pharmacology, research and professional practice, in addition to continue researching molecular pharmacology of cannabinoids and opioids.

External positions

Liaison Pharmacist , Nepean Blue Mountains Local Health District

Jul 2016Jan 2017

Community Pharmacist, Dee Why Grand Pharmacy

May 2011Jun 2016

Fingerprint Dive into the research topics where Marina Junqueira Santiago is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Outputs

  • 160 Citations
  • 5 h-Index
  • 11 Article

Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists

Sachdev, S., Banister, S. D., Santiago, M., Bladen, C., Kassiou, M. & Connor, M., 1 Apr 2020, In : Pharmacology Research & Perspectives. 8, 2, p. 1-10 10 p., e00566.

Research output: Contribution to journalArticle

Open Access
  • 3 Downloads (Pure)

    Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

    Gillis, A., Gondin, A. B., Kliewer, A., Sanchez, J., Lim, H. D., Alamein, C., Manandhar, P., Santiago, M., Fritzwanker, S., Schmidel, F., Katte, T. A., Reekie, T., Grimsey, N. L., Kassiou, M., Kellam, B., Krasel, C., Halls, M. L., Connor, M., Lane, J. R., Schulz, S. & 2 others, Christie, M. J. & Canals, M., 31 Mar 2020, In : Science Signaling. 13, 625, p. 1-18 18 p., eaaz3140.

    Research output: Contribution to journalArticle

  • Open Access
  • 6 Citations (Scopus)
    9 Downloads (Pure)

    Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells

    Sachdev, S., Boyd, R., Grimsey, N. L., Santiago, M. & Connor, M., 25 Sep 2019, In : PeerJ. 2019, 9, p. 1-15 15 p., e7733.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Downloads (Pure)

    Cannabichromene is a Cannabinoid CB2 receptor agonist

    Udoh, M., Santiago, M., Devenish, S., McGregor, I. & Connor, M., Dec 2019, In : British Journal of Pharmacology. 176, 23, p. 4537-4547 11 p.

    Research output: Contribution to journalArticle

  • 2 Citations (Scopus)


    • 2 Publication Peer-review
    • 1 Oral presentation

    PeerJ (Journal)

    Marina Santiago (Reviewer)

    Activity: Publication peer-review and editorial workPublication Peer-review

    British Journal of Pharmacology (Journal)

    Marina Junqueira Santiago (Reviewer)

    Activity: Publication peer-review and editorial workPublication Peer-review